Nuvalent to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

01.04.25 12:30 Uhr

Werte in diesem Artikel

CAMBRIDGE, Mass., April 1, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter, Ph.D., Chief Executive Officer, and Alexandra Balcom, Chief Financial Officer, will participate in a fireside chat during the Stifel 2025 Virtual Targeted Oncology Forum on Tuesday, April 8, 2025, at 2:30 p.m. ET.

Nuvalent, Inc. (PRNewsfoto/Nuvalent, Inc.)

A live webcast will be available in the Investors section of the company's website at www.nuvalent.com, and archived for 30 days following the presentations.

About Nuvalent
Nuvalent, Inc. (Nasdaq: NUVL) is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with investigational candidates for ROS1-positive, ALK-positive, and HER2-altered non-small cell lung cancer, and multiple discovery-stage research programs.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nuvalent-to-participate-in-the-stifel-2025-virtual-targeted-oncology-forum-302416418.html

SOURCE Nuvalent, Inc.

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und als Geschenk eine Gratisaktie erhalten.

Ausgewählte Hebelprodukte auf Nuvalent A

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Nuvalent A

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Nuvalent Inc Registered Shs -A-

Wer­bung